Back
ESC Premium Access

Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

Session: TAVI: a new standard for aortic valve replacement?
Topic: Aortic valve disease
Speaker: Doctor B. Alushi (Munich, DE)
Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor Brunilda Alushi

Heart Center Alter Hof, Munich (Germany)
0 follower

4 more presentations in this session

State of the Art: TAVI indications and adoption: a dynamic field

Speaker: Professor B. Prendergast (London, GB)

Access
Video
Thumbnail

Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.

Speaker: Professor E. Durand (Rouen, FR)

Access
Abstract
Slides
Video
Thumbnail

Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)

Speaker: Doctor U. Fischer-Rasokat (Bad Nauheim, DE)

Access
Abstract
Thumbnail

TAVI complications: incidence, trends and management.

Speaker: Professor A. Chieffo (Milan, IT)

Access
Slides
Video
Thumbnail

Access the full session

TAVI: a new standard for aortic valve replacement?

Speakers: Doctor B. Alushi, Professor B. Prendergast, Professor E. Durand, Doctor U. Fischer-Rasokat, Professor A. Chieffo
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb